CDEK
← All organizations

Galecto Biotech

For profit

Also known as: Galecto Biotech AB

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Sep 1, 2014

Last known activity

Jun 10, 2026

Acquired by Bristol-Myers Squibb on Jan 1, 2014

Timeline

2010s

  1. Jan 1, 2011

    Galecto Biotech— Founded

  2. Jan 1, 2014

    Bristol-Myers Squibb— Acquired By

2020s

  1. Jan 7, 2020

    PharmAkea, Inc.— Acquired

Drugs by trial phase (7 distinct, 11 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (11)

Details

Founded
Copenhagen, DK Jan 1, 2011
Last known activity
Jun 10, 2026